Supplemental Annuity Collective Trust (SACT) of New Jersey’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $755K | Sell |
13,098
-686
| -5% | -$39.4K | 0.19% | 99 |
|
|
2026
Q1 | $836K | Sell |
13,784
-11,216
| -45% | -$654K | 0.24% | 82 |
|
|
2025
Q4 | $1.35M | Hold |
25,000
| – | – | 0.35% | 62 |
|
|
2025
Q3 | $1.13M | Hold |
25,000
| – | – | 0.3% | 78 |
|
|
2025
Q2 | $1.16M | Hold |
25,000
| – | – | 0.33% | 68 |
|
|
2025
Q1 | $1.52M | Hold |
25,000
| – | – | 0.48% | 48 |
|
|
2024
Q4 | $1.41M | Hold |
25,000
| – | – | 0.42% | 53 |
|
|
2024
Q3 | $1.29M | Hold |
25,000
| – | – | 0.38% | 65 |
|
|
2024
Q2 | $1.04M | Hold |
25,000
| – | – | 0.32% | 76 |
|
|
2024
Q1 | $1.36M | Hold |
25,000
| – | – | 0.42% | 57 |
|
|
2023
Q4 | $1.28M | Hold |
25,000
| – | – | 0.45% | 58 |
|
|
2023
Q3 | $1.45M | Hold |
25,000
| – | – | 0.55% | 35 |
|
|
2023
Q2 | $1.6M | Hold |
25,000
| – | – | 0.57% | 34 |
|
|
2023
Q1 | $1.73M | Hold |
25,000
| – | – | 0.68% | 25 |
|
|
2022
Q4 | $1.8M | Hold |
25,000
| – | – | 0.75% | 27 |
|
|
2022
Q3 | $1.78M | Hold |
25,000
| – | – | 0.78% | 21 |
|
|
2022
Q2 | $1.93M | Hold |
25,000
| – | – | 0.77% | 21 |
|
|
2022
Q1 | $1.83M | Hold |
25,000
| – | – | 0.6% | 30 |
|
|
2021
Q4 | $1.56M | Hold |
25,000
| – | – | 0.48% | 47 |
|
|
2021
Q3 | $1.48M | Sell |
25,000
-12,000
| -32% | -$790K | 0.49% | 50 |
|
|
2021
Q2 | $2.47M | Hold |
37,000
| – | – | 0.8% | 20 |
|
|
2021
Q1 | $2.34M | Hold |
37,000
| – | – | 0.81% | 21 |
|
|
2020
Q4 | $2.29M | Hold |
37,000
| – | – | 0.85% | 20 |
|
|
2020
Q3 | $2.23M | Hold |
37,000
| – | – | 0.93% | 17 |
|
|
2020
Q2 | $2.18M | Hold |
37,000
| – | – | 0.99% | 16 |
|
|
2020
Q1 | $2.06M | Hold |
37,000
| – | – | 1.14% | 14 |
|
|
2019
Q4 | $2.38M | Buy |
37,000
+15,000
| +68% | +$859K | 0.98% | 17 |
|
|
2019
Q3 | $1.12M | Hold |
22,000
| – | – | 0.51% | 46 |
|
|
2019
Q2 | $998K | Buy |
22,000
+1,000
| +5% | +$46.6K | 0.44% | 55 |
|
|
2019
Q1 | $1M | Sell |
21,000
-5,000
| -19% | -$249K | 0.45% | 65 |
|
|
2018
Q4 | $1.35M | Hold |
26,000
| – | – | 0.69% | 33 |
|
|
2018
Q3 | $1.61M | Hold |
26,000
| – | – | 0.67% | 29 |
|
|
2018
Q2 | $1.44M | Buy |
26,000
+2,000
| +8% | +$108K | 0.62% | 39 |
|
|
2018
Q1 | $1.52M | Hold |
24,000
| – | – | 0.66% | 31 |
|
|
2017
Q4 | $1.47M | Buy |
24,000
+2,000
| +9% | +$125K | 0.62% | 35 |
|
|
2017
Q3 | $1.4M | Buy |
22,000
+2,000
| +10% | +$117K | 0.62% | 43 |
|
|
2017
Q2 | $1.11M | Hold |
20,000
| – | – | 0.5% | 62 |
|
|
2017
Q1 | $1.09M | Sell |
20,000
-5,211
| -21% | -$286K | 0.49% | 68 |
|
|
2016
Q4 | $1.47M | Hold |
25,211
| – | – | 0.7% | 41 |
|
|
2016
Q3 | $1.36M | Hold |
25,211
| – | – | 0.67% | 43 |
|
|
2016
Q2 | $1.85M | Hold |
25,211
| – | – | 0.93% | 26 |
|
|
2016
Q1 | $1.61M | Hold |
25,211
| – | – | 0.82% | 29 |
|
|
2015
Q4 | $1.73M | Hold |
25,211
| – | – | 0.88% | 29 |
|
|
2015
Q3 | $1.49M | Hold |
25,211
| – | – | 0.79% | 32 |
|
|
2015
Q2 | $1.68M | Hold |
25,211
| – | – | 0.8% | 31 |
|
|
2015
Q1 | $1.63M | Hold |
25,211
| – | – | 0.76% | 34 |
|
|
2014
Q4 | $1.49M | Hold |
25,211
| – | – | 0.7% | 38 |
|
|
2014
Q3 | $1.29M | Hold |
25,211
| – | – | 0.63% | 41 |
|
|
2014
Q2 | $1.22M | Hold |
25,211
| – | – | 0.59% | 44 |
|
|
2014
Q1 | $1.31M | Hold |
25,211
| – | – | 0.65% | 38 |
|
|
2013
Q4 | $1.34M | Hold |
25,211
| – | – | 0.66% | 39 |
|
|
2013
Q3 | $1.17M | Hold |
25,211
| – | – | 0.63% | 40 |
|
|
2013
Q2 | $1.13M | Buy |
+25,211
| New | +$1.09M | 0.64% | 38 |
|
Other funds holding BMY
Supplemental Annuity Collective Trust (SACT) of New Jersey's BMY Position: Q2 2026 in Review
Supplemental Annuity Collective Trust (SACT) of New Jersey reduced its Bristol-Myers Squibb (BMY) stake by 5% in Q2 2026, selling an estimated $39.4K and leaving 13,098 shares worth $755K. The position accounts for 0.19% of the portfolio, ranked #99.
Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.47M in Q2 2021. 1,973 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Supplemental Annuity Collective Trust (SACT) of New Jersey held 13,098 shares of Bristol-Myers Squibb worth $755K as of Q2 2026.
- Supplemental Annuity Collective Trust (SACT) of New Jersey sold 686 Bristol-Myers Squibb shares in Q2 2026, an estimated $39.4K.
- Bristol-Myers Squibb made up 0.19% of Supplemental Annuity Collective Trust (SACT) of New Jersey's portfolio in Q2 2026, its #99 holding.
- Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- Supplemental Annuity Collective Trust (SACT) of New Jersey's Bristol-Myers Squibb position peaked at $2.47M in Q2 2021.
- 1,973 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Supplemental Annuity Collective Trust (SACT) of New Jersey's 13F filing for Q2 2026, filed 27 Jul 2026.